HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hydrogen-rich University of Wisconsin solution attenuates renal cold ischemia-reperfusion injury.

AbstractBACKGROUND:
Renal ischemia-reperfusion (I/R) injury is unavoidable in kidney transplantation and frequently influences both short- and long-term allograft survival rates. One of the major events in I/R injury is the generation of cytotoxic oxygen radicals. Recently, hydrogen gas has been reported to display antioxidant properties and protective effects against organ dysfunction induced by various I/R injuries. We investigated whether hydrogen-rich University of Wisconsin (HRUW) solution attenuates renal cold I/R injury.
METHODS:
We prepared HRUW solution by a novel method involving immersion of centrifuge tubes containing UW solution into hydrogen-saturated water. Hydrogen readily permeates through the centrifuge tubes, and thus, the hydrogen concentration of the UW solution gradually increases in a time-dependent manner. Syngeneic rat kidney transplantation was performed, and the animals were divided into three groups: recipients with nonpreserved grafts (control group), recipients with grafts preserved in UW solution for 24 to 48 hr (UW group), and recipients with grafts preserved in HRUW solution for 24 to 48 hr (HRUW group).
RESULTS:
In the early phases, HRUW solution decreased oxidative stress, tubular apoptosis, and interstitial macrophage infiltration in the kidney grafts. Consequently, HRUW solution improved renal function and prolonged recipient survival rate compared with simple cold storage using UW solution. Histopathologically, HRUW treatment alleviated tubular injury and suppressed development of interstitial fibrosis.
CONCLUSIONS:
HRUW solution improved graft function and prolonged graft survival compared with simple cold storage using UW solution by protecting tubular epithelial cells from inflammation and apoptosis. Our new method of organ preservation is a groundbreaking, safe, and simple strategy that may be applied in the clinical setting.
AuthorsToyofumi Abe, Xiao-Kang Li, Koji Yazawa, Naoyuki Hatayama, Lin Xie, Bunpei Sato, Yoichi Kakuta, Koichi Tsutahara, Masayoshi Okumi, Hidetoshi Tsuda, Jun-ya Kaimori, Yoshitaka Isaka, Michiya Natori, Shiro Takahara, Norio Nonomura
JournalTransplantation (Transplantation) Vol. 94 Issue 1 Pg. 14-21 (Jul 15 2012) ISSN: 1534-6080 [Electronic] United States
PMID22683850 (Publication Type: Journal Article)
Chemical References
  • Insulin
  • Organ Preservation Solutions
  • University of Wisconsin-lactobionate solution
  • Allopurinol
  • Hydrogen
  • Glutathione
  • Adenosine
  • Raffinose
Topics
  • Adenosine (pharmacology)
  • Allopurinol (pharmacology)
  • Animals
  • Apoptosis
  • Cold Temperature
  • Glutathione (pharmacology)
  • Graft Survival
  • Hydrogen (pharmacology)
  • Insulin (pharmacology)
  • Kidney (blood supply)
  • Kidney Transplantation
  • Kidney Tubules (pathology)
  • Macrophages (physiology)
  • Male
  • Organ Preservation Solutions (pharmacology)
  • Oxidative Stress
  • Raffinose (pharmacology)
  • Rats
  • Rats, Inbred Lew
  • Reperfusion Injury (prevention & control)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: